Financial Enhancement »

United Therapeutics Corporation shares owned by Financial Enhancement

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Financial Enhancement from 13F filings

Historical chart of Financial Enhancement investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Financial Enhancement consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Financial Enhancement

Quarter filed Position value Share count Share price at filing
2023-03-31 $3.9M 19k 212.05
2022-12-31 $4.3M 17k 252.78
2022-09-30 $3.5M 17k 209.36
2022-06-30 $3.9M 17k 235.63

More positions owned by Financial Enhancement

Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr Index Shs Fds Msci Eafe Strtgc (QEFA)
Simplify Exchange Traded Fun Short Term Trea (TUA)
Janus Detroit Str Tr Henderson Securi (JSI)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
First Tr Exch Traded Fd Iii Lng/sht Equity (FTLS)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Amplify Etf Tr Cwp Enhanced Div (DIVO)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Linde SHS (LIN)
Ishares Tr S&p 100 Etf (OEF)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Visa Com Cl A (V)

View all positions for Financial Enhancement

Top funds holding United Therapeutics Corporation

Vanguard Group
Wellington Management Company
venBio Select Advisor
Henderson Group
Dimensional Fund Advisors
Bank of New York Mellon
AQR Capital Management
Norges Bank Investment Management
Palo Alto Investors
OrbiMed Advisors
LSV Asset Management
Charles Schwab Investment Management
Pacer Advisors
Caisse de depot et placement du Quebec
Legal & General Group

View all funds holding United Therapeutics Corporation